Excessively redundant umbilical skin as a potential early clinical feature of Morquio syndrome and FKBP14‐related Ehlers–Danlos syndrome
Abstract
Several umbilical abnormalities have been linked to and utilized to aid in the clinical diagnosis of certain syndromes. For instance, umbilical skin redundancy has long been recognized as a core feature of Rieger syndrome although its association with other disorders is unknown. In this article, we report for the first time the occurrence of this distinct clinical sign in association with two other syndromes: Morquio syndrome and FKBP14‐related Ehlers–Danlos syndrome (EDS). Our observation is clinically significant because patients with Morquio syndrome are often diagnosed only after they develop typical skeletal manifestations, which reduces the efficacy of available enzyme replacement therapy, so the umbilical sign we report here can facilitate a much earlier diagnosis. In addition, the extreme rarity of FKBP14‐related Ehlers–Danlos syndrome (EDS) can greatly delay the diagnosis of this condition unless it is recognized in the differential diagnosis of redundant umbilical skin as we argue in this report.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Four different FKBP14 mutations have been identified to date.
“Four different FKBP14 mutations have been identified to date [Baumann et al., 2012;Aldeeri et al., 2014;Murray et al., 2014;Dordoni et al., 2016].”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Aldeeri et al., 2014
To date, 10 patients with kEDS-FKBP14 from nine independent families have been described.
“To date, 10 patients with kEDS-FKBP14 from nine independent families have been described: Five pediatric (<12 years), three adolescents (16 years), and two adults (42-and 48-year-old) (Table S1) [Baumann et al., 2012, Aldeeri et al., 2014, Murray et al., 2014, Alazami et al., 2016, Dordoni et al., 2016].”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Aldeeri et al., 2014
Cites
Baumann, M., Giunta, C., Krabichler, B., Rüschendorf, F., Zoppi, N., Colombi, M., Bittner, R. E., Quijano-Roy, S., Muntoni, F., Cirak, S., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.12.004 · Cited by 162 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Ehlers–Danlos syndromes, rare types
Brady, A. F., Demirdas, S., Fournel‐Gigleux, S., Ghali, N., Giunta, C., Kapferer‐Seebacher, I., Kosho, T., Mendoza‐Londono, R., Pope, M. F., Rohrbach, M., et al. (2017) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31550 · Cited by 249 · see citing works
Molecular insights into prolyl and lysyl hydroxylation of fibrillar collagens in health and disease
Gjaltema, R. A. F., & Bank, R. A. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2016.1269716 · Cited by 175 · see citing works
Dordoni, C., Ciaccio, C., Venturini, M., Calzavara‐Pinton, P., Ritelli, M., & Colombi, M. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37728 · Cited by 20 · see citing works
Genetics of the Ehlers–Danlos syndrome: More than collagen disorders
Van Damme, T., Syx, D., Coucke, P., Symoens, S., De Paepe, A., & Malfait, F. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1022528 · Cited by 4 · see citing works
- Authors
- Aldeeri, A. A., Alazami, A. M., Hijazi, H., Alzahrani, F., & Alkuraya, F. S.
- Affiliations
- King Faisal Specialist Hospital & Research Centre (SA)
- Alfaisal University (SA)
- Corresponding author
- Alkuraya, F.S.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2014-05-22
- Volume
- 86
- Issue
- 5
- Pages
- 469-472
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W1506360056
- Cited by
- 17
- References
- 1
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2020: 2 · 2018: 1 · 2017: 4 · 2016: 4 · 2015: 2
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- Morquio syndrome, Ehlers-Danlos syndrome, early diagnosis, Rieger syndrome, differential diagnosis, enzyme replacement therapy
- MeSH terms
- Child, Child, Preschool, Ehlers-Danlos Syndrome, Female, Humans, Infant, Infant, Newborn, Male, Mucopolysaccharidosis IV, Skin Abnormalities, Umbilicus, Peptidylprolyl Isomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review